Статті в журналах з теми "RSA advisors/referents"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "RSA advisors/referents".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Carande, Robert. "Reference Advisory Systems (RAS): Some Practical Issues." Reference Services Review 17, no. 3 (March 1989): 87–90. http://dx.doi.org/10.1108/eb049069.
Ambrogi, Federica. "Elisa Paini (1863-1924). Wife and «unbeatable collaborator» of Luigi Credaro." Rivista di Storia dell’Educazione 7, no. 2 (December 4, 2020): 133–44. http://dx.doi.org/10.36253/rse-9865.
Walker, Christopher J., Junke Wang, Alyssa I. Clay-Gilmour, Krzysztof Mrózek, Deedra Nicolet, Christopher C. Oakes, Jessica Kohlschmidt, et al. "Meta-Analysis of Genome-Wide Association Studies of Acute Myeloid Leukemia (AML) Patients Identifies Variants Associated with Risk of 11q23/KMT2A-Translocated and Core-Binding Factor (CBF) AML and Suggests a Role for Transcription Elongation in Leukemogenesis." Blood 136, Supplement 1 (November 5, 2020): 29–30. http://dx.doi.org/10.1182/blood-2020-141653.
Visconte, Valeria, Bartlomiej P. Przychodzen, Vera Adema, Cassandra M. Hirsch, Allison Noe, Rachel Toth, Christina Snider, et al. "Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies." Blood 132, Supplement 1 (November 29, 2018): 211. http://dx.doi.org/10.1182/blood-2018-99-116411.
Yalniz, Fevzi F., Rima M. Saliba, Orhan K. Yucel, Guillermo Garcia-Manero, Jeremy Ramdial, Uday Popat, Stefan O. Ciurea, et al. "Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation." Blood 134, Supplement_1 (November 13, 2019): 512. http://dx.doi.org/10.1182/blood-2019-125937.
Murphy, Tracy, Stanley W. K. Ng, Tong Zhang, Ian King, Andrea Arruda, Jaime O. Claudio, Narmin Ibrahimova, et al. "Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients." Blood 134, Supplement_1 (November 13, 2019): 2682. http://dx.doi.org/10.1182/blood-2019-130532.
Mahevas, Matthieu, Stephanie Guillet, Jean-Francois Viallard, Delphine Gobert, Marion Malphettes, Stephane Cheze, Francois Lefrere, et al. "Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)." Blood 138, Supplement 1 (November 5, 2021): 583. http://dx.doi.org/10.1182/blood-2021-152767.
Tomaz, Victória, Karina Griesi-Oliveira, Renato D. Puga, Fabio Pires de Souza Santos, Nelson Hamerschlak, and Paulo Vidal Campregher. "Identification of Gene Networks Associated with the Anti-Leukemic Effect of Anti-Inflammatory Drugs on Acute Myeloid Leukemia Cell Lines." Blood 138, Supplement 1 (November 5, 2021): 4343. http://dx.doi.org/10.1182/blood-2021-153903.
Perumal, Deepak, Alessandro Lagana', Alex Rubinsteyn, John P. Finnigan, Pei-Yu Kuo, Violetta V. Leshchenko, Ajai Chari, et al. "Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma." Blood 126, no. 23 (December 3, 2015): 1851. http://dx.doi.org/10.1182/blood.v126.23.1851.1851.
Yao, Lijun, Reyka G. Jayasinghe, Beena E. Thomas, Swati S. Bhasin, Nicolas Fernandez, Taxiarchis Kourelis, Deon Doxie, et al. "Integrated Cytof, Scrna-Seq and Cite-Seq Analysis of Bone Marrow Immune Microenvironment in the Mmrf Commpass Study." Blood 136, Supplement 1 (November 5, 2020): 28–29. http://dx.doi.org/10.1182/blood-2020-142534.
Pelham, Robert J., Xuguang Hu, Philippe Moreau, Albert Oriol, Hang Quach, Tibor Kovacsovics, Jonathan J. Keats, Shibao Feng, Amy S. Kimball, and Meletios A. Dimopoulos. "Genomic Predictors of Progression-Free Survival Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Carfilzomib and Dexamethasone or Bortezomib and Dexamethasone in the Phase 3 Endeavor Trial." Blood 130, Suppl_1 (December 7, 2017): 839. http://dx.doi.org/10.1182/blood.v130.suppl_1.839.839.
Mageau, Arthur, Louis Terriou, Mikael Ebbo, Odile Souchaud-Debouverie, Corentin Orvain, Julie Graveleau, Jean-Christophe Lega, et al. "Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment." Blood 138, Supplement 1 (November 5, 2021): 17. http://dx.doi.org/10.1182/blood-2021-147450.
Brummaier, Tobias, Basirudeen Syed Ahamed Kabeer, Stephen Lindow, Justin C. Konje, Sasithon Pukrittayaamee, Juerg Utzinger, Mohammed Toufiq, et al. "A prospective cohort for the investigation of alteration in temporal transcriptional and microbiome trajectories preceding preterm birth: a study protocol." BMJ Open 9, no. 1 (January 2019): e023417. http://dx.doi.org/10.1136/bmjopen-2018-023417.
Croucher, Danielle C., Marta Chesi, Zhihua Li, Victoria Marie Garbitt, Meaghen E. Sharik, Daniel Waller, Michael Sebag, P. Leif Bergsagel, Trevor J. Pugh, and Suzanne Trudel. "A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma." Blood 132, Supplement 1 (November 29, 2018): 56. http://dx.doi.org/10.1182/blood-2018-99-118691.
Nicolini, Franck E., Vincent Alcazer, Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Stephane Morisset, Christophe Bouvier, Francois-Xavier Mahon, Gabriel Etienne, and Delphine Rea. "The Outcome of Treatment-Free Remission after First-Line Nilotinib or Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients Is Different." Blood 138, Supplement 1 (November 5, 2021): 2552. http://dx.doi.org/10.1182/blood-2021-146722.
Roeser, Anais, Guillaume Moulis, Mikael Ebbo, Louis Terriou, Elsa Poullot, Bertrand Lioger, Marie Chilles, et al. "A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia." Blood 138, Supplement 1 (November 5, 2021): 3167. http://dx.doi.org/10.1182/blood-2021-153388.
Bloehdorn, Johannes, Julia Krzykalla, Billy Michael Chelliah Jebaraj, Karlheinz Holzmann, Jasmin Bahlo, Sandra Robrecht, Kathryn Humphrey, et al. "MYC Pathway Activation Is Frequently Observed in Treatment-Naive CLL and Defines a Subgroup with Particular Benefit from the Addition of Rituximab to Chemotherapy." Blood 132, Supplement 1 (November 29, 2018): 1866. http://dx.doi.org/10.1182/blood-2018-99-116937.
Fulciniti, Mariateresa, Charles Y. Lin, Mehmet K. Samur, Matthew Lawlor, Kenneth C. Anderson, James E. Bradner, and Nikhil C. Munshi. "Discovery and Characterization of Promoter and Super-Enhancer-Associated Dependencies through E2F and BET Bromodomains in Multiple Myeloma." Blood 126, no. 23 (December 3, 2015): 838. http://dx.doi.org/10.1182/blood.v126.23.838.838.
van Beers, Erik H., Martin H. Van Vliet, Kenneth C. Anderson, Ajai Chari, Sundar Jagannath, Andrzej Jakubowiak, Shaji K. Kumar, et al. "High Risk Multiple Myeloma Cases Are Identified In An MMRC Led Study By The SKY92 Gene Signature (MMprofiler)." Blood 122, no. 21 (November 15, 2013): 1854. http://dx.doi.org/10.1182/blood.v122.21.1854.1854.
Asmann, Yan, Ying Li, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, Henan Zhang, Anatilde Gonzalez Guerrico, et al. "Single Cell Transcriptome Profile of Myeloma and Immune Cell Characteristics in Patients with Durable Response Post CART." Blood 138, Supplement 1 (November 5, 2021): 3838. http://dx.doi.org/10.1182/blood-2021-153254.
Murphy, Tracy, Stanley W. K. Ng, Ian King, Tong Zhang, Andrea Arruda, Narmin Ibrahimova, Jaime O. Claudio, et al. "Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA." Blood 136, Supplement 1 (November 5, 2020): 35–36. http://dx.doi.org/10.1182/blood-2020-138943.
Catalano, Calogerina, Joanna Blocka, Stefanie Huhn, Nagarajan Paramasivam, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, et al. "Characterization of Rare Germline Variants in Familial Multiple Myeloma." Blood 136, Supplement 1 (November 5, 2020): 45–46. http://dx.doi.org/10.1182/blood-2020-142253.
Tirier, Stephan M., Jan-Philipp Mallm, Nicola Casiraghi, Hana Susak, Nicola Giesen, Alexandra M. Poos, Katharina Bauer, et al. "Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma." Blood 134, Supplement_1 (November 13, 2019): 571. http://dx.doi.org/10.1182/blood-2019-128625.
Maeding, Nicole, Daniela Asslaber, Nadja Zaborsky, Andreas Villunger, Richard Greil, and Alexander Egle. "Lack of Bmf Facilitates the Selection of Highly Responsive B-Cell Receptor Clones in Chronic Lymphocytic Leukemia." Blood 138, Supplement 1 (November 5, 2021): 1543. http://dx.doi.org/10.1182/blood-2021-152216.
Garg, Tarun K., Ricky D. Edmondson, Shweta S. Chavan, Katie Stone, Justin M. Stivers, Jessica I. Warden, Veronica Macleod, et al. "Differential ICAM3 Gene Expression Correlates with Susceptibility to Natural Killer Cell-Mediated Lysis in Multiple Myeloma." Blood 126, no. 23 (December 3, 2015): 2990. http://dx.doi.org/10.1182/blood.v126.23.2990.2990.
Mehr, Shaadi, Daniel Auclair, Mark Hamilton, Leon Rozenblit, Hearn Jay Cho, Lijun Yao, Reyka G. Jayasinghe, et al. "Architecture of Sample Preparation and Data Governance of Immuno-Genomic Data Collected from Bone Marrow and Peripheral Blood Samples Obtained from Multiple Myeloma Patients." Blood 136, Supplement 1 (November 5, 2020): 17–18. http://dx.doi.org/10.1182/blood-2020-142882.
Tarantino, Michael D., Michael Vredenburg, Wei Tian, Brian Jamieson, and Kashyap B. Patel. "Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag." Blood 136, Supplement 1 (November 5, 2020): 23–24. http://dx.doi.org/10.1182/blood-2020-142788.
White, Brian S., Suleiman A. Khan, Muhammad Ammad-ud-din, Swapnil Potdar, Mike J. Mason, Cristina E. Tognon, Brian J. Druker, et al. "Comparative Analysis of Independent Ex Vivo functional Drug Screens Identifies Predictive Biomarkers of BCL-2 Inhibitor Response in AML." Blood 132, Supplement 1 (November 29, 2018): 2763. http://dx.doi.org/10.1182/blood-2018-99-111916.
Mishima, Yuji, Michele Moschetta, Jiantao Shi, Francois Mercier, Salomon Manier, Siobhan Glavey, Michaela R. Reagan, et al. "Clonal-Heterogeneity and Propensity for Bone Metastasis in Multiple Myeloma." Blood 124, no. 21 (December 6, 2014): 3370. http://dx.doi.org/10.1182/blood.v124.21.3370.3370.
Wang, Tianjiao, Hua Sun, Daniel Cui Zhou, Ruiyang Liu, Lijun Yao, Mark A. Fiala, Daniel R. Kohnen, et al. "Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease Stages." Blood 134, Supplement_1 (November 13, 2019): 364. http://dx.doi.org/10.1182/blood-2019-131361.
Spencer, Andrew, Tiffany Khong, and Maoshan Chenn. "MCL-1 Inhibitor-Induced Killing of Multiple Myeloma Is Modulated By the Relative Level of Expression of Pro-Survival Members of the BCL-2 Family and the Proto-Oncogene MYC." Blood 134, Supplement_1 (November 13, 2019): 1825. http://dx.doi.org/10.1182/blood-2019-127843.
Matino, Davide, Giancarlo Castaman, Giovanni Di Minno, Paola Giordano, Maria Elisa Mancuso, Emanuela Marchesini, Flora Peyvandi, et al. "Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study." Blood 132, Supplement 1 (November 29, 2018): 3781. http://dx.doi.org/10.1182/blood-2018-99-119568.
Wallace, Sarah, Victoria Hall, Andre Charlett, Peter D. Kirwan, Michele Cole, Natalie Gillson, Ana Atti, et al. "Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol." BMJ Open 12, no. 6 (June 2022): e054336. http://dx.doi.org/10.1136/bmjopen-2021-054336.
Lee, Shawn, Federico Antillón, Deqing Pei, Wenjian Yang, Kathryn G. Roberts, Zhenhua Li, Meenakshi Devidas, et al. "The Impact of Genetic Ancestry on the Biology and Prognosis of Childhood Acute Lymphoblastic Leukemia." Blood 138, Supplement 1 (November 5, 2021): 3476. http://dx.doi.org/10.1182/blood-2021-145655.
Sauer, Sandra, Christos Sachpekidis, Simone Brandelik, Daniel Spira, Stefanie Huhn, Barbara Wagner, Manuela Hummel, et al. "Prospective Evaluation of 18-F FDG PET/CT and Biopsies of Osteolytic Lesions and Random Bone Marrow Samples in Newly Diagnosed Multiple Myeloma Patients." Blood 132, Supplement 1 (November 29, 2018): 3180. http://dx.doi.org/10.1182/blood-2018-99-115201.
Roter, Kyle, Donglei Hu, Alyssa Clay-Gilmour, Scott Huntsman, Nina D. Shah, Sandy W. Wong, Thomas G. Martin, et al. "Germline Variation Predicts Treatment Response in Multiple Myeloma." Blood 134, Supplement_1 (November 13, 2019): 4397. http://dx.doi.org/10.1182/blood-2019-129344.
Poos, Alexandra M., Jan-Philipp Mallm, Stephan M. Tirier, Nicola Casiraghi, Hana Susak, Nicola Giesen, Katharina Bauer, et al. "A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma." Blood 134, Supplement_1 (November 13, 2019): 575. http://dx.doi.org/10.1182/blood-2019-130051.
Coffey, David G., Francesco Maura, Edgar Gonzalez-Kozlova, Javier Diaz-Mejia3, Ping Luo, Yong Zhang, Yuexin Xu, et al. "Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma." Blood 138, Supplement 1 (November 5, 2021): 329. http://dx.doi.org/10.1182/blood-2021-154506.
Sheih, Alyssa, Jonathan L. Golob, Abir Bhattacharyya, Michael C. Wu, Aesha Vakil, Sujatha Srinivasan, Steven A. Pergam, David N. Fredricks, and Cameron J. Turtle. "Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation." Blood 132, Supplement 1 (November 29, 2018): 3393. http://dx.doi.org/10.1182/blood-2018-99-115158.
McCarthy, John J. "Alan S. Kaye (ed.) (1997). Phonologies of Asia and Africa (including the Caucasus). Technical advisor: Peter T. Daniels. Winona Lake, Indiana: Eisenbrauns. 2 vols. Pp. xxi+1041." Phonology 15, no. 1 (August 1998): 111–14. http://dx.doi.org/10.1017/s0952675798003509.
Arkian, Muhammad Reyzha Noorsyam, M. Subur Drajat, and Dadi Ahmadi. "Peran Public Relations dalam Film Hancock." Inter Komunika : Jurnal Komunikasi 3, no. 2 (December 11, 2018): 145. http://dx.doi.org/10.33376/ik.v3i2.214.
Decroocq, Justine, Rudy Birsen, Jordi Mano, Guillemette Fouquet, Mathilde Gotanègre, Laury Poulain, Sarah Mouche, et al. "Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models." Blood 134, Supplement_1 (November 13, 2019): 2671. http://dx.doi.org/10.1182/blood-2019-123418.
Zhang, Haiyu, Bing Zhang, Xiangqian Guo, Naznin Haq, Robert B. West, James B. Bussel, and James L. Zehnder. "Effects of Thrombopoietin Mimetics on Patients with Chronic ITP: Perspectives from Blood Transcriptome Profiling Analysis." Blood 124, no. 21 (December 6, 2014): 2780. http://dx.doi.org/10.1182/blood.v124.21.2780.2780.
Bai, Xiaoying, Jennifer Trowbridge, Joseph Lee, Stuart H. Orkin, and Leonard I. Zon. "Analysis of TIF1gamma Conditional Knockout Establishes a Requirement for the Differentiation of Multiple Hematopoietic Lineages." Blood 116, no. 21 (November 19, 2010): 744. http://dx.doi.org/10.1182/blood.v116.21.744.744.
Sharma, Priyanka, Sujan Piya, Huaxian Ma, Natalia Baran, Malgorzata Anna Zal, Christopher J. Hindley, Kim-Hien Dao, et al. "ERK1/2 Inhibition Overcomes Resistance in Acute Myeloid Leukemia (AML) and Alters Mitochondrial Dynamics." Blood 138, Supplement 1 (November 5, 2021): 3338. http://dx.doi.org/10.1182/blood-2021-151579.
Stahlberg, Eric, Lynn Borkon, Ruth Frost, Sara Jones, Amar Khalsa, Lauren Lewis, Emily Greenspan, and Sunita Menon. "Abstract 7432: Improving FAIRness of computational approaches for cancer: The computational resources for cancer research portal." Cancer Research 84, no. 6_Supplement (March 22, 2024): 7432. http://dx.doi.org/10.1158/1538-7445.am2024-7432.
Kumar, Ashwini, Muntasir Mamun Majumder, Jesus María Lopez Martí, Alun Parsons, Pirkko Mattila, Kimmo Porkka, Olli Kallioniemi, and Caroline A. Heckman. "The Use of RNA Sequencing to Identify Disease-Specific Gene Expression Signatures and Critical Regulatory Networks Across Hematologic Malignancies." Blood 124, no. 21 (December 6, 2014): 2203. http://dx.doi.org/10.1182/blood.v124.21.2203.2203.
Chen, Zhenghao, Gaspard Cretenet, Beatriz Valle-Argos, Francesco Forconi, Arnon P. Kater, Graham Packham, and Eric Eldering. "Effects of Ibrutinib on Metabolic Alterations and Micro-Environmental Signalling in Chronic Lymphocytic Leukaemia." Blood 136, Supplement 1 (November 5, 2020): 36–37. http://dx.doi.org/10.1182/blood-2020-142839.
Clarke, Stanley R., Adrianna Vlachos, Jens Lichtenberg, Nancy E. Seidel, Jaya Jagadeesh, NISC Comparative SequencingProgram, Adam M. Phillippy, et al. "Whole Genome Sequencing of Diamond Blackfan Anemia Syndrome Patients Detects Mutations That Alter mRNA Splicing." Blood 138, Supplement 1 (November 5, 2021): 863. http://dx.doi.org/10.1182/blood-2021-145622.
Su, Christopher T., Liying Chen, Jason Chen, Brian Parkin, Avery Polk, Malathi Kandarpa, Craig E. Cole, et al. "Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM)." Blood 136, Supplement 1 (November 5, 2020): 45–46. http://dx.doi.org/10.1182/blood-2020-134558.